Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report

Novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan, China. Since then, COVID-19 has become a pandemic affecting more than 4.1 million people worldwide. Patients with COVID-19 have a wide spectrum of manifestations, one being cytokine release syndrome (CRS) and its fatal...

Descripción completa

Detalles Bibliográficos
Autores principales: Radbel, Jared, Narayanan, Navaneeth, Bhatt, Pinki J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195070/
https://www.ncbi.nlm.nih.gov/pubmed/32343968
http://dx.doi.org/10.1016/j.chest.2020.04.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195070/
https://www.ncbi.nlm.nih.gov/pubmed/32343968
http://dx.doi.org/10.1016/j.chest.2020.04.024

Ejemplares similares